John Fesko, the PRESIDENT of $NTRA, sold 2,415 shares of the company on 02-03-2026 for an estimated $558,203. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.3% of their shares of this class of stock. Following this trade, they now own 178,081 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 201 times in the past 6 months. Of those trades, 0 have been purchases and 201 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 23 sales selling 284,332 shares for an estimated $58,777,430.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 10 sales selling 105,000 shares for an estimated $19,781,053.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 22 sales selling 76,513 shares for an estimated $17,727,601.
- ROELOF BOTHA has made 0 purchases and 11 sales selling 75,000 shares for an estimated $17,708,935.
- JONATHAN SHEENA has made 0 purchases and 74 sales selling 60,983 shares for an estimated $12,321,985.
- HERM ROSENMAN has made 0 purchases and 4 sales selling 48,419 shares for an estimated $11,011,477.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 25 sales selling 48,727 shares for an estimated $10,707,393.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 9 sales selling 26,713 shares for an estimated $6,067,144.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 11 sales selling 26,177 shares for an estimated $5,995,820.
- ROY D. BAYNES has made 0 purchases and 8 sales selling 12,780 shares for an estimated $2,809,688.
- ROWAN E CHAPMAN has made 0 purchases and 3 sales selling 7,116 shares for an estimated $1,520,611.
- GAIL BOXER MARCUS sold 122 shares for an estimated $24,242
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 410 institutional investors add shares of $NTRA stock to their portfolio, and 293 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 1,003,129 shares (+9.4%) to their portfolio in Q3 2025, for an estimated $161,473,675
- POINTSTATE CAPITAL LP added 985,963 shares (+702.0%) to their portfolio in Q3 2025, for an estimated $158,710,464
- FRANKLIN RESOURCES INC added 727,366 shares (+37.5%) to their portfolio in Q3 2025, for an estimated $117,084,105
- AQR CAPITAL MANAGEMENT LLC added 673,315 shares (+39.0%) to their portfolio in Q3 2025, for an estimated $108,383,515
- INVESCO LTD. removed 649,956 shares (-34.7%) from their portfolio in Q3 2025, for an estimated $104,623,417
- AMERIPRISE FINANCIAL INC removed 626,686 shares (-67.0%) from their portfolio in Q3 2025, for an estimated $100,877,645
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 616,695 shares (+67.9%) to their portfolio in Q3 2025, for an estimated $99,269,394
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Revenue
$NTRA had revenues of $592.2M in Q3 2025. This is an increase of 34.66% from the same period in the prior year.
You can track NTRA financials on Quiver Quantitative's NTRA stock page.
$NTRA Congressional Stock Trading
Members of Congress have traded $NTRA stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/22, 08/22 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- BTIG issued a "Buy" rating on 12/05/2025
- JP Morgan issued a "Overweight" rating on 11/25/2025
- UBS issued a "Buy" rating on 11/18/2025
- Stephens & Co. issued a "Overweight" rating on 11/13/2025
- Piper Sandler issued a "Overweight" rating on 11/11/2025
- Morgan Stanley issued a "Overweight" rating on 11/11/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
$NTRA Price Targets
Multiple analysts have issued price targets for $NTRA recently. We have seen 12 analysts offer price targets for $NTRA in the last 6 months, with a median target of $262.5.
Here are some recent targets:
- Patrick Donnelly from Citigroup set a target price of $300.0 on 01/07/2026
- Subbu Nambi from Guggenheim set a target price of $270.0 on 01/05/2026
- Kyle Mikson from Canaccord Genuity set a target price of $285.0 on 12/22/2025
- Luke Sergott from Barclays set a target price of $270.0 on 12/15/2025
- Brandon Couillard from Wells Fargo set a target price of $205.0 on 12/15/2025
- Casey Woodring from JP Morgan set a target price of $260.0 on 12/15/2025
- Mark Massaro from BTIG set a target price of $260.0 on 12/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
